Convergent Modifiers of Exposure Variability in Approved Cannabinoid Medicines: Pharmacogenomics, Drug-Drug Interactions, and Parent-Metabolite Divergence.

Bagher AM

Open source

DOI
10.3390/pharmaceutics18101293
Published
2026 Oct 12
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18101293,
  title = {Convergent Modifiers of Exposure Variability in Approved Cannabinoid Medicines: Pharmacogenomics, Drug-Drug Interactions, and Parent-Metabolite Divergence.},
  author = {Bagher AM},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18101293},
  url = {https://doi.org/10.3390/pharmaceutics18101293}
}

RIS

TY  - JOUR
TI  - Convergent Modifiers of Exposure Variability in Approved Cannabinoid Medicines: Pharmacogenomics, Drug-Drug Interactions, and Parent-Metabolite Divergence.
AU  - Bagher AM
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18101293
UR  - https://doi.org/10.3390/pharmaceutics18101293
ER  - 

APA

AM, B. (2026). Convergent Modifiers of Exposure Variability in Approved Cannabinoid Medicines: Pharmacogenomics, Drug-Drug Interactions, and Parent-Metabolite Divergence.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18101293

Source records